Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 3Completed 3Terminated 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Head and Neck Neoplasms 330Nasopharyngeal Carcinoma 223Squamous Cell Carcinoma of Head and Neck 205Thyroid Neoplasms 123Mouth Neoplasms 70Nasopharyngeal Neoplasms 55Thyroid Nodule 52Laryngeal Neoplasms 43Oropharyngeal Neoplasms 42Breast Neoplasms 42Neoplasms 33Neoplasm Metastasis 29Thyroid Cancer, Papillary 28Lung Neoplasms 27Hypopharyngeal Neoplasms 27Colorectal Neoplasms 26Carcinoma, Non-Small-Cell Lung 25Esophageal Neoplasms 23Recurrence 22Pancreatic Neoplasms 22Stomach Neoplasms 21Carcinoma, Squamous Cell 21Thyroid Diseases 20Prostatic Neoplasms 19Stomatitis 18Ovarian Neoplasms 18Salivary Gland Neoplasms 17Melanoma 17Uterine Cervical Neoplasms 15Radiation Injuries 15

Interventions

Panobinostat 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hereditary Sensory and Autonomic Neuropathies × Head & Neck × Clear all
NCT01341834 2018-04-24

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

National Cancer Centre, Singapore

Phase 1 Unknown
49 enrolled
Head & NeckLymphoid

Nasopharyngeal Carcinoma, Lymphoma, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡